Sign up to save your podcasts
Or
Share Expanding Precision Oncology With Targeted Immunotherapy
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Expanding Precision Oncology With Targeted Immunotherapy
Dr. Pedro Barata and Dr. Bridget Keenan discuss the innovative bioengineering allowing clinicians to target historically "immune-cold" tumors, the logistical evolution of bringing bispecific therapies safely into outpatient community clinics, and the complex future of predictive biomarkers and resistance mechanisms.
LINK TO FULL TRANSCRIPT
View all episodes
By American Society of Clinical Oncology (ASCO)
4.5
3131 ratings
Dr. Pedro Barata and Dr. Bridget Keenan discuss the innovative bioengineering allowing clinicians to target historically "immune-cold" tumors, the logistical evolution of bringing bispecific therapies safely into outpatient community clinics, and the complex future of predictive biomarkers and resistance mechanisms.
LINK TO FULL TRANSCRIPT
More shows like ASCO Education
View all
NEJM This Week
319 Listeners
Journal of Clinical Oncology (JCO) Podcast
40 Listeners
JCO Oncology Practice Podcast
17 Listeners
ASCO Daily News
58 Listeners
The Curbsiders Internal Medicine Podcast
3,364 Listeners
ASCO Guidelines
46 Listeners
The Readout Loud
340 Listeners
OncLive® On Air
24 Listeners
Money Meets Medicine
229 Listeners
Oncology Today with Dr Neil Love
59 Listeners
The Foreign Affairs Interview
472 Listeners
Not Otherwise Specified
60 Listeners
Two Onc Docs
196 Listeners
Oncology Brothers: Practice-Changing Cancer Discussions
47 Listeners
The Best People with Nicolle Wallace
4,360 Listeners